SAMSUNG PHARM. Co., LTD.

KRX:001360.KS

1518 (KRW) • At close September 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20232022202120202019201820172016201520142013201220112010200920082007
Operating Activities:
Net Income -24,812.022-25,093.031-40,276.344-39,876.9796,885.174-2,075.706-7,539.887-21,617.603-994.392-23,748.181-18,488.79-3,132.252-1,748.025-906.231,316.511634.209-2,356.85
Depreciation & Amortization 1,913.7513,007.4253,203.4544,199.4484,215.7133,764.0583,915.3184,266.7782,478.971,473.4421,376.1991,109.9991,122.6111,037.5161,127.7291,107.1571,049.38
Deferred Income Tax 00000000000000000
Stock Based Compensation 00000000000000000
Change In Working Capital -16,057.6681,563.626-212.872-2,585.336-3,928.117-6,826.5974,962.633-2,441.536-3,550.942-13,052.1754,666.278-12,884.898-5,080.104-9,898.331-11,042.677-3,254.399-2,941.059
Accounts Receivables 441.3552,789.4073,819.034421.627-1,394.849-1,978.618369.5931,067.0722,838.2700000000
Inventory -14,437.24-1,723.788-4,123.041-4,006.036-3,602.782802.1751,191.975-5,931.308-4,092.69-604.894,353.588-2,356.397-2,370.762332.14-2,106.872-980.904-497.578
Accounts Payables 1,131.367-569.255-277.559-291.2972,245.658-1,535.9232,458.1251,564.071-2,634.26900000000
Other Working Capital -3,193.151,067.262368.6941,290.37-1,176.144-7,628.7723,770.6573,489.772541.748-12,447.285312.69-10,528.501-2,709.342-10,230.471-8,935.805-2,273.495-2,443.481
Other Non Cash Items 11,298.63118,607.730,122.97435,709.632-9,607.087-1,382.2834,201.0269,850.98-2,138.58621,743.57913,049.9673,780.5754,057.9985,497.6624,944.5892,593.4042,756.141
Operating Cash Flow -27,657.308-1,914.28-7,162.788-2,553.235-2,434.317-6,520.5285,539.09-9,941.381-4,204.949-13,583.335603.654-11,126.576-1,647.52-4,269.383-3,653.8481,080.371-1,492.388
Investing Activities:
Investments In Property Plant And Equipment -12,779.783-3,034.827-4,065.486-7,154.445-13,880.939-3,692.447-6,387.012-34,341.816-17,605.933-2,092.134-2,077.759-2,492.128-1,307.137-1,397.771-919.017-1,996.062-1,174.905
Acquisitions Net 7.455058,907.361,0087,373.051,078.557-4,000-1,031.062-3,700-99.995000-21.716-34.176-22.51214.124
Purchases Of Investments -31,875.913-70,899.999-67,020.322-11,919.556-4,818.216-15,003.392-15,009.997-15,187.537-6,197.100-1,068.9610-270.301-290.6-225-4,205
Sales Maturities Of Investments 42,004.43152,60019,897.26810,790.95918,106.0864,906.3992,05521,710.3252,208.769087.340340.4965904.1783,0001,230.962
Other Investing Activites 7.33234,159.01411,266.491664.1661,869.0256,112.4231,083.059506.799-26,214.4353,645.8690040.149-839.85-459.732-179.49545.001
Investing Cash Flow -2,636.47912,824.18818,985.31-6,610.8768,649.005-6,598.461-22,258.95-28,343.291-51,508.71,453.74-1,990.419-3,561.089-926.491-1,939.638-1,699.347576.931-4,089.818
Financing Activities:
Debt Repayment -318.3620-11,667.72-5,608.732-4,093.493-17,894.357-5,356.303-22,376.819-4,189.198-14,506.273-9,769.757-3,438.580-258.782-18.99-2,405.402-16,002.052
Common Stock Issued 0009,988.108031,233.083040,809.97618,344.63827,749.9510000000
Common Stock Repurchased 00000000-1,389.19800000000
Dividends Paid 00000000000000000
Other Financing Activities -1,104.4580-543.91826,253.512-225.38024,7705,65057,122.2621,689.5873,196.5426,061.6982,594.415,500.9615,066.514716,006
Financing Cash Flow -1,422.82-1,004.704-12,211.63830,632.888-4,318.87313,338.72619,413.69724,083.15771,277.70314,933.265-6,573.21722,623.1182,594.415,242.1795,047.51-2,258.4023.948
Other Information:
Effect Of Forex Changes On Cash 11.817-16.54541.721-71.1160-0-5,152.396-0911.11200000000
Net Change In Cash -31,704.799,888.659-347.39521,397.6611,895.815219.737-2,458.56-14,201.51616,475.1662,803.67-7,959.9827,935.45320.399-966.842-305.685-601.1-5,578.258
Cash At End Of Period 4,281.30835,986.09826,097.43926,444.8345,047.1733,151.3582,931.625,390.1819,591.6963,116.53312.868,272.842337.389316.9911,283.8331,589.5182,190.618